Kungokuqala kwezinyathelo ezintathu zokukhula kwezinwele
Kunezigaba ezintathu zokukhula kwezinwele : owokuqala yi-anagen (ebizwa ngokuthi: ANN-uh-jin) isigaba, okwesibili kuthiwa yi-catagen (eyaziwa ngokuthi: KAT-uh-jin) isigaba, kanti isigaba sesithathu sibizwa ngokuthi i- telogen isigaba.
Isigaba se-anagen yisigaba sokukhula esikhulayo sezinwele zezinwele . Phakathi nalesi sigaba, izinwele zikhula cishe ngamentimitha eyodwa, noma cishe ingxenye yesigamu, njalo ezinsukwini ezingu-28.
I-Anagen Phase
Futhi phakathi nalesi sigaba, amangqamuzana empandeni yezinwele ahlukanisa ngokushesha, engeza kwi-shaft yezinwele. Izinwele ze-Scalp zihlala kulesi sigaba esisebenzayo sokukhula iminyaka emibili kuya kweyisithupha. Noma nini, cishe amaphesenti angaba ngu-80 kuya kwamaphesenti angu-90 wezinwele ezisekhanda lakho asezingeni lika-anagen.
Isikhathi sesikhathi u-follicle wezinwele ehlala esigabeni se-anagen sithathwa ngokwezakhi zofuzo. Abanye abantu ngokwemvelo banama-anagen phases futhi bangakwazi ukukhula izinwele zabo isikhathi eside, kanti abanye ngeke babone izinwele zabo zithole isikhathi eside kunanyawo nangesigamu. Ekupheleni kwesigaba se-anagen, isignali engaziwa ibangela ukuthi i-follicle ingene esigabeni se-catagen.
I-Catagen Phase
Isigaba se-catagen yisigaba esincane sokuguquka esenzeka ekupheleni kwesigaba se-anagen. Ikhombisa ukuphela kokukhula okusebenzayo kwezinwele. Izinwele zixosha egazini lazo ngesikhathi sesigaba se-catagen. Lesi sigaba sihlala cishe amasonto amabili kuya kwamathathu ngenkathi kubonakala izinwele zeqembu .
Isigaba se-Telogen
Ngemuva kwesigaba esincane esifundeni, izinwele zikhishwa futhi izinwele zezinwele zihlala izinyanga ezintathu. Izinwele zeqembu ziphuma ngaphandle. Ngokuvamile, ulahlekelwa izinwele ezingu-50 kuya ku-100 ngosuku. Ngemuva kwezinyanga ezintathu, i-follicle ibuyela emuva ku-anagen bese iqala ukukhula izinwele ezintsha.
Kubalulekile ukuqaphela ukuthi zonke izinwele azihambisani nalezi zigaba ngesikhathi esifanayo.
Isizathu sokuthi ungahambi ngesikhashana okwesikhashana ukuthi, nganoma yisiphi isikhathi, ezinye izinwele zikhona esigabeni se-anagen, ezinye izinwele zisesigaba se-catagen, kanti ezinye izinwele zikhona esigabeni se-telogen.
Yini Engayichaza Isigaba Sakho Sokuqala?
Abantu abakukudla okukhawulelwe ngekhalori banganciphisa isigaba sabo se-anagen. Lokhu kungenzeka futhi ngenxa yokucindezeleka, ukubeletha, noma izenzakalo ezibuhlungu. Izinwele ezingaphezulu zezinwele zingena esikhungweni se-telogen ngesikhathi esifanayo futhi ungabona ukulahlekelwa kwezinwele ezidlulayo , okubizwa ngokuthi i- telogen effluvium . Kukhona futhi i-anagen effluvium evela kumakhemikhali, imisebe, noma amakhemikhali anobuthi. Lezi ziphazamisa izinwele ngenkathi zisendaweni ye-anagen. Kulezi zimo, izinwele zivame ukubuyiselwa ekugcwaleni kwayo. Ukupheka okuphindaphindiwe kokudliwa noma i-chemotherapy kuzoqhubeka nephethini.
Kunezimo ezingavamile zabantu abane-anagen syndrome, lapho bengasoze bakhula khona izinwele ezinde ngenxa yezizathu ezingaziwa. Laba bantu bazothi bangakaze badinge ukunqunywa kwezinwele.
Loose Anagen Syndrome
I-loose anagen syndrome ibonakala kwezinye izingane . Banezinwele ezincane futhi izinwele zabo zikhishwa kalula, nezimpande zibonisa ukuthi zisesigaba se-anagen. Kungaba yisimo esizuze njengefa futhi ngokuvamile kuvame njengoba ingane ikhula.
Abagqugquzeli be-Anagen
Ezinye imikhiqizo yezinwele zibiza ngokuthi i-anagen stimulators ezingenza ukuthi izinwele zihambe ezingeni lika-anagen noma zisize izinwele zihlale isikhathi eside ku-anagen. Ngaphambi kokuba usebenzise noma yikuphi kwalezi zinto ezingaphezu kwamakhompiyutha, ukhulume kuqala kudokotela, mhlawumbe i- dermatologist (udokotela ogxile ekunakekeleni izinwele, isikhumba, nezipikili), futhi ubuze ukuthi kukhona uphenyo olubuyekezwe kontanga olusekela isimangalo .
> Imithombo:
> Kanwar AJ, Narang T. "Anagen effluvium." Indian J Dermatol Venereol Leprol. 2013 Sep-Oct; 79 (5): 604-12. doi: 10.4103 / 0378-6323.116728.
> Giacomini F, Starace M, uTosti A. "I-short anagen syndrome." I-Pediatr Dermatol. 2011 Mar-Apr; 28 (2): 133-4. i-doi: 10.1111 / j.1525-1470.2010.01165.x.